An MRI procedure that does not use contrast agents may reduce the number of unnecessary breast biopsies.
Diffusion kurtosis imaging, an MR imaging technique that does not require contrast agents, reduces the number of unnecessary breast biopsies, according to a study published in the journal Radiology.
Researchers from Germany sought to evaluate a radiomics model of BI-RADS 4 and 5 breast lesions extracted from breast-tissue-optimized kurtosis MR imaging for lesion characterization.
“Diffusion kurtosis imaging has been introduced in DWI to provide important information on tissue structures at a microscopic level,” lead author Sebastian Bickelhaupt, MD, from the German Cancer Research Center in Heidelberg, Germany, said in a release. “Since malignant lesions disrupt the tissue structures at this level, diffusion kurtosis might serve as a relevant marker of changes.”
A total of 222 women from two sites participated in the study.
The women had suspicious findings on mammography that were classified as BI-RADS 4 and 5 breast lesions. The women underwent DWI followed by biopsy. The researchers used a software algorithm developed for lesion characterization, and imaging features were extracted using a kurtosis-based radiomics model.
The results showed the radiomics analysis reduced false-positive findings by 70 percent, while detecting 60 of 61 malignant lesions (98 percent). The model significantly improved specificity compared with the median apparent diffusion coefficient and apparent kurtosis coefficient alone. Conventional
reading of dynamic contrast material–enhanced MR imaging provided sensitivity of 91.8 percent (56 of 61) and a specificity of 74.2 percent (49 of 66). Accounting for fat signal intensity during fitting significantly improved the area under the curve of the model.
“The model might help to lower the number of BI-RADS 4 lesions suspected of being cancer on the basis of screening mammography while retaining a high sensitivity similar to the sensitivity reported for biopsies themselves,” co-lead author Paul Jaeger, MSc, said in the same release.
According to Bickelhaupt, the new approach is not intended to replace current contrast-enhanced breast MRI protocols in general, but to expand the spectrum of options available for answering specific clinical questions.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Reducing the Interval Breast Cancer Rate of Screening DBT: Can AI Have an Impact?
July 29th 2025In a retrospective review of screening digital breast tomosynthesis (DBT) exams for over 200 women with interval breast cancers, researchers found that AI provided accurate localization of cancers in 32.6 percent of the cases.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
July 22nd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.